Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00PFT
|
|||
| Drug Name |
PMID26293650-Compound-34
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
DOMAINEX LIMITED PERRIOR, Trevor, Robert NEWTON, Gary, Karl STEWART, Mark, Richard AQIL, Rehan
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C25H26N6O
|
|||
| Canonical SMILES |
CC(C)NC(=O)C1=CC=C(C=C1)NC2=NC=CC(=N2)C3=CC(=C(C=C3)N4CCCC4)C#N
|
|||
| InChI |
1S/C25H26N6O/c1-17(2)28-24(32)18-5-8-21(9-6-18)29-25-27-12-11-22(30-25)19-7-10-23(20(15-19)16-26)31-13-3-4-14-31/h5-12,15,17H,3-4,13-14H2,1-2H3,(H,28,32)(H,27,29,30)
|
|||
| InChIKey |
FJNGYFUMQJIPOQ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | NF-kappa-B-activating kinase (TBK1) | Target Info | Inhibitor | [1] |
| Target's Patent Info | NF-kappa-B-activating kinase (TBK1) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | TBK1 inhibitors: a review of patent literature (2011 - 2014).Expert Opin Ther Pat. 2015;25(12):1385-96. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.